These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Results of tests for micronuclei and chromosomal aberrations in mouse bone marrow cells with the human carcinogens 4-aminobiphenyl, treosulphan, and melphalan. Shelby MD, Gulati DK, Tice RR, Wojciechowski JP. Environ Mol Mutagen; 1989; 13(4):339-42. PubMed ID: 2737185 [Abstract] [Full Text] [Related]
14. [Novel Bis-sulfonic Acid Esters with Cytostatic Activity (author's transl)]. Senning A, Buchholt HC, Bierling R. Arzneimittelforschung; 1976; 26(10):1800-9. PubMed ID: 191037 [Abstract] [Full Text] [Related]
15. Dose-dependent cytotoxic and mutagenic effects of antineoplastic alkylating agents on human lymphoblastoid cells. Sanderson BJ, Johnson KJ, Henner WD. Environ Mol Mutagen; 1991; 17(4):238-43. PubMed ID: 2050131 [Abstract] [Full Text] [Related]
16. Mutagenicity of the human carcinogen treosulphan, and its hydrolysis product, dl-1,2:3,4-diepoxybutane in mammalian cells. Zhu S, Zeiger E. Environ Mol Mutagen; 1993; 21(1):95-9. PubMed ID: 8419160 [Abstract] [Full Text] [Related]
17. Treosulphan, myleran and butadiene: similarities and differences. Ashby J. Mutat Res; 1993 Jul; 300(2):77-8. PubMed ID: 7685496 [No Abstract] [Full Text] [Related]
19. Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications. Beelen DW, Trenschel R, Casper J, Freund M, Hilger RA, Scheulen ME, Basara N, Fauser AA, Hertenstein B, Mylius HA, Baumgart J, Pichlmeier U, Hahn JR, Holler E. Bone Marrow Transplant; 2005 Feb; 35(3):233-41. PubMed ID: 15592494 [Abstract] [Full Text] [Related]